PRESCRIBING · PART D · 2024
Total Rx claims
852
Beneficiaries
—
Total drug cost
$9.3M
Distinct drugs
9
Brand share
74.8%
Top prescribed drugs
Zanubrutinib321 claims
Acalabrutinib Maleate173 claims
Acyclovir152 claims
Venetoclax59 claims
Ibrutinib56 claims
QUALITY · MIPS · 2024
Final MIPS score
95.2
Quality
83.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.85%
APM Entity
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CROSS-REFERENCE